- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Bethlehem Today
By the People, for the People
OraSure Technologies Stock Crosses Above 200-Day Moving Average
Shares of the medical device company see a price increase as they surpass a key technical indicator.
Mar. 31, 2026 at 6:11am
Got story updates? Submit your updates here. ›
Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) crossed above their 200-day moving average on Monday, trading as high as $2.99 per share. The stock closed the day at $2.92, with a trading volume of over 400,000 shares. OraSure Technologies is a Bethlehem, Pennsylvania-based diagnostic and medical device company that specializes in point-of-care and self-testing products, including its flagship OraQuick rapid HIV test.
Why it matters
Crossing above the 200-day moving average is often seen as a bullish technical indicator, suggesting the stock may be entering a period of positive momentum. However, analysts currently have a 'Reduce' rating on OraSure's stock, with a consensus price target of $3.00 per share.
The details
OraSure Technologies shares have a 50-day simple moving average of $2.90 and a 200-day simple moving average of $2.78. The company has a market capitalization of $201.86 million, a price-to-earnings ratio of -3.14, and a beta of 0.88. In the company's most recent earnings report, it posted a loss of $0.19 per share, missing analyst estimates.
- OraSure Technologies shares crossed above the 200-day moving average on Monday, March 30, 2026.
- The company last reported earnings on Wednesday, February 25, 2026.
The players
OraSure Technologies, Inc.
A Bethlehem, Pennsylvania-based diagnostic and medical device company that specializes in the development, manufacture and commercialization of point-of-care and self-testing products, including its flagship OraQuick rapid HIV test.
Weiss Ratings
A financial research firm that has issued a 'sell (d)' rating on shares of OraSure Technologies.
What they’re saying
“We must not let individuals continue to damage private property in San Francisco.”
— Robert Jenkins, San Francisco resident
The takeaway
While crossing above the 200-day moving average is generally seen as a positive technical signal, OraSure Technologies' stock currently has a 'Reduce' rating from analysts, who cite concerns about the company's recent financial performance. Investors will be closely watching to see if the stock can build on this momentum and regain investor confidence.


